A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
Sponsor
Control Delivery Systems (Industry)
Overall Status
Unknown status
CT.gov ID
NCT00032396
Collaborator
Bausch & Lomb Incorporated (Industry)
1
Study Details
Study Description
Brief Summary
A study evaluating Retisert in patients with age-related macular degeneration
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 2 |
Study Design
Study Type:
Interventional
Primary Purpose:
Treatment
Study Start Date
:
Nov 1, 2001
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
55 Years
to 0 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Control Delivery Systems, Inc. | Watertown | Massachusetts | United States | 02472 |
Sponsors and Collaborators
- Control Delivery Systems
- Bausch & Lomb Incorporated
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00032396
Other Study ID Numbers:
- CDS FL-004
First Posted:
Mar 22, 2002
Last Update Posted:
May 29, 2006
Last Verified:
Dec 1, 2002
Keywords provided by ,
,
Additional relevant MeSH terms: